Sionna Therapeutics (SION) Free Cash Flow (2024 - 2026)
Sionna Therapeutics' (SION) quarterly Free Cash Flow came in at -$21.8 million in Q1 2026, down 33.38% year-on-year from -$32.8 million in Q1 2025, and down 29.77% quarter-over-quarter from -$16.8 million in Q4 2025.
Sionna Therapeutics (SION) Free Cash Flow (2024 - 2026) Analysis & Trends
Sionna Therapeutics has disclosed Free Cash Flow across 3 years of filings, most recently posting -$21.8 million for Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$21.8 million, down 33.38% year-over-year; the trailing twelve-month figure through Mar 2026 was -$72.1 million (down 28.79% YoY), and the FY2025 annual result was -$66.7 million, down 26.24% from the prior year.
- Free Cash Flow came in at -$21.8 million for Q1 2026 at Sionna Therapeutics, down from -$16.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$10.1 million in Q2 2024 to a low of -$21.8 million in Q1 2026.
- The 3-year median for Free Cash Flow is -$16.4 million (2025), against an average of -$15.7 million.
- Peak annual rise in Free Cash Flow reached 13.39% in 2025, while the deepest fall reached 78.94% in 2025.
- Sionna Therapeutics' Free Cash Flow stood at -$11.8 million in 2024, then sank by 42.53% to -$16.8 million in 2025, then slipped by 29.77% to -$21.8 million in 2026.
- The last three Free Cash Flow figures came in at -$21.8 million (Q1 2026), -$16.8 million (Q4 2025), and -$15.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 63,220.27 |
| 10 | Sionna Therapeutics | 1.61 Bn | 1.61 Bn | - | -21.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.84 Mn |
| Mar 31, 2026 | -21.84 Mn |
| Dec 31, 2025 | -16.83 Mn |
| Dec 31, 2025 | -16.83 Mn |
| Sep 30, 2025 | -15.32 Mn |
| Sep 30, 2025 | -15.32 Mn |
| Jun 30, 2025 | -18.15 Mn |
| Jun 30, 2025 | -18.15 Mn |
| Mar 31, 2025 | -16.37 Mn |
| Mar 31, 2025 | -16.37 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Sep 30, 2024 | -17.69 Mn |
| Sep 30, 2024 | -17.69 Mn |
| Jun 30, 2024 | -10.15 Mn |
| Jun 30, 2024 | -10.15 Mn |
| Mar 31, 2024 | -13.18 Mn |
| Mar 31, 2024 | -13.18 Mn |